Bosh sahifa068270 • KRX
add
Celltrion Inc
Yopilish kursi
197 200,00 ₩
Kunlik diapazon
200 000,00 ₩ - 207 000,00 ₩
Yillik diapazon
144 615,31 ₩ - 251 000,00 ₩
Bozor kapitalizatsiyasi
47,60 trln KRW
Oʻrtacha hajm
560,82 ming
Narx/foyda
44,21
Dividend daromadliligi
0,36%
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,33 trln | 25,06% |
Joriy xarajat | 383,06 mlrd | 10,26% |
Sof foyda | 528,43 mlrd | 123,30% |
Sof foyda marjasi | 39,73 | 78,56% |
Har bir ulushga tushum | 2,40 ming | 117,62% |
EBITDA | 537,36 mlrd | 95,28% |
Amaldagi soliq stavkasi | -0,01% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,24 trln | 8,40% |
Jami aktivlari | 22,33 trln | 6,08% |
Jami passivlari | 4,98 trln | 43,37% |
Umumiy kapital | 17,35 trln | — |
Tarqatilgan aksiyalar | 218,61 mln | — |
Narxi/balansdagi bahosi | 2,51 | — |
Aktivlardan daromad | 5,42% | — |
Kapitaldan daromad | 5,77% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 528,43 mlrd | 123,30% |
Operatsiyalardan naqd pul | 139,88 mlrd | -54,28% |
Sarmoyadan naqd pul | -629,48 mlrd | -520,17% |
Moliyadan naqd pul | 754,75 mlrd | 429,67% |
Naqd pulning sof oʻzgarishi | 309,21 mlrd | 1 200,88% |
Boʻsh pul | -160,53 mlrd | -362,61% |
Haqida
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Tashkil etilgan
2002
Sayt
Xodimlar soni
1 074
